Back to search

Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons

Data up to Jan 2025

Published1993
Citations105
References55

Total Citations Per Year

Abstract

References (55)

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

1983 • 4,822 citations

AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY

1991 • 3,275 citations

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1983 • 2,149 citations

Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease

1988 • 1,881 citations

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1979 • 1,356 citations

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1988 • 1,235 citations

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1984 • 913 citations

Recent Developments in Parkinson's Disease

1987 • 552 citations

Hyperactivity of Remaining Dopaminergic Neurones after Partial Destruction of the Nigro-striatal Dopaminergic System in the Rat

1973 • 363 citations

Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys

1986 • 347 citations

Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1986 • 309 citations

Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey

1991 • 219 citations

Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP

1987 • 163 citations

The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism

1990 • 145 citations

III. Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys

1985 • 134 citations

Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum

1989 • 134 citations

Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys

1986 • 128 citations

Symptomatic and asymptomatic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated primates: Biochemical changes in striatal regions

1989 • 126 citations

Evidence for neuromelanin involvement in MPTP-induced neurotoxicity

1987 • 120 citations

The nigrostriatal system in Parkinson's disease.

1990 • 114 citations

I. Parkinson's disease: Studies with an animal model

1984 • 111 citations

Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A tyrosine hydroxylase immunocytochemical study in monkey

1986 • 102 citations

Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism

1992 • 99 citations

Advances in Neurology, vol 53, Parkinson's Disease: Anatomy, Pathology, and Therapy

1991 • 98 citations

Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys

1986 • 91 citations

Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists

1990 • 87 citations

The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.

1986 • 86 citations

N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey.

1984 • 75 citations

The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (mptp) and its relevance to parkinson's disease

1987 • 74 citations

The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease

1988 • 74 citations

The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey

1990 • 64 citations

Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology

1988 • 59 citations

The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐tetrahydropyridine to monkeys

1991 • 54 citations

Neurodegenerative disorders - the role played by endotoxins and xenobiotics.

1988 • 51 citations

Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primates

1991 • 50 citations

Tremorgenic mechanisms in primates.

1975 • 48 citations

MPTP produces a pattern of nigrostriatal degeneration which coincides with the mosaic organization of the caudate nucleus

1988 • 48 citations

Reversal of the glabellar reflex in Parkinsonism by L-dopa.

1969 • 47 citations

MPTP-induced parkinsonism in monkeys: Mechanism of action, selectivity and pathophysiology

1988 • 42 citations

Electrophysiological evidence for a facio-facial reflex in the facial muscles in man

1977 • 32 citations

Intracarotid 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Administration: Biochemical and Behavioral Observations in a Primate Model of Hemiparkinsonism

1990 • 32 citations

Tremor in MPTP‐induced parkinsonism

1992 • 32 citations

Stereotaxic lesions and movement disorders in monkeys.

1975 • 30 citations

“In vivo” visualization by positron emission tomography of the progressive striatal dopamine receptor damage occuring in MPTP-intoxicated non-human primates

1986 • 27 citations

Motor impairments and neurochemical changes after unilateral 6-hydroxydopamine lesion of the nigrostriatal dopaminergic system in monkeys

1990 • 25 citations

Nigral degeneration in Parkinson's disease in relation to clinical features

1991 • 24 citations

Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTP

1987 • 22 citations

Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1988 • 19 citations

Habituation of the Blink Reflex

2015 • 17 citations

Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: A review

1991 • 16 citations

Alterations of the central noradrenergic system in MPTP-induced monkey parkinsonism.

1988 • 13 citations

MPTP and its relevance to parkinson's disease

1987 • 7 citations

Habituation of the blink reflex

1981 • 7 citations

Chronic administration of MPTP to marmosets.

1990 • 5 citations

Analyse électrophysiologique du réflexe de clignement chez l'Homme normal et en clinique neurologique

1972 • 2 citations

Cited By (0)

Loading...